FTRE Fortrea Holdings Inc

MIXED Impact: 6/10 PRESS-RELEASE
Horizon days Filed May 5, 2026 Processed 1mo ago Wire GlobeNewswire
Press release: earnings
Latest settled — T+20d ⚠ clustered
FTRE ▲ +5.71% at T+20d
NEUTRAL call ✓ call won +5.71% · α vs SPY +0.76% · entry $14.53 → $15.36
Next anchor: T+60d in 7w
Currently $16.88 · +16.17% from $14.53 entry
Entry anchored
May 5, 2026
via day open
T+1d
+7.64%
call +7.64% · α +6.25%
$15.64
settled 5w ago
T+5d
+0.55%
call +0.55% · α -1.43%
$14.61
settled 29d ago
T+20d
+5.71%
call +5.71% · α +0.76%
$15.36
settled 7d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Fortrea reported Q1 2026 adjusted EPS of $0.16, significantly above the $0.05 consensus, though GAAP EPS was -$0.25 due to non-cash items. Revenue of $636.5M slightly exceeded the $625.9M estimate but declined 2.3% YoY from $651.3M. The company affirmed full-year 2026 guidance for revenue of $2.55B-$2.65B and adjusted EBITDA of $190M-$220M, with a strong 1.15x book-to-bill ratio signaling improving demand.

Key Financial Metrics

Guidance
$2,550M-$2,650M
maintained
Free Cash Flow
-$25.0M

Actionable Insight

The strong adjusted EPS beat and 1.15x book-to-bill signal improving operational momentum, but YoY revenue decline and negative free cash flow temper enthusiasm. Watch for Q2 2026 revenue growth inflection and margin expansion trajectory to confirm the turnaround narrative.

Key Facts

  • Q1 2026 revenue $636.5M vs consensus $625.9M (beat) but down from $651.3M YoY (-2.3%)
  • Adjusted diluted EPS $0.16 vs consensus $0.05 (beat) and vs $0.02 YoY
  • GAAP net loss -$23.6M (-$0.25/diluted share) vs -$562.9M (-$6.25) YoY, which included a $488.8M goodwill impairment
  • Adjusted EBITDA $47.0M vs $30.3M YoY, up 55%
  • Book-to-bill ratio 1.15x, third consecutive quarter above 1.1x; backlog $7,846M
  • Full-year 2026 guidance affirmed: revenue $2.55B-$2.65B, adjusted EBITDA $190M-$220M
  • Operating cash flow -$17.0M; free cash flow -$25.0M in Q1

Financial Impact

Adjusted EPS beat consensus by $0.11 (220% surprise); revenue beat by $10.6M (1.7% surprise). Adjusted EBITDA improved $16.7M YoY.

revenueepsadjustedEbitdabookToBill

Risk Factors

  • Revenue still declining YoY (-2.3%) despite beat vs consensus
  • Negative free cash flow of -$25.0M in Q1
  • GAAP net loss persists; adjusted metrics mask underlying cash burn
  • Full-year guidance maintained, not raised, despite strong Q1 beat

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
59% bullish (17 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3287436
8 reports for FTRE
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for FTRE — sortable, filterable
Type Now
Jun 2, 2026
7d ago
Press Release
NEUTRAL ★ 2/10
$15.63 $17.25▲ +10.36%▲ +9.97%$16.88 (+8.00%)
May 5, 2026
5w ago
8-K
MIXED ★ 5/10
$14.53 $15.64▲ +7.64%▲ +6.25%$16.88 (+16.17%)
May 5, 2026
5w ago
Press Release
MIXED ★ 6/10
$14.53 $15.64▲ +7.64%▲ +6.25%$16.88 (+16.17%)
Apr 27, 2026
6w ago
DEFA14A
NEUTRAL ★ 2/10
$10.60 $10.76▲ +1.51%▲ +1.99%$16.88 (+59.25%)
Mar 16, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$9.27 $9.70▲ +4.64%▲ +4.37%$16.88 (+82.09%)
Mar 16, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$9.27 $9.70▲ +4.64%▲ +4.37%$16.88 (+82.09%)
Mar 10, 2026
13w ago
Press Release
NEUTRAL ★ 3/10
$9.42 $9.04▼ −4.03%▼ −2.55%$16.88 (+79.19%)
Feb 26, 2026
14w ago
8-K
BEARISH ★ 7/10
$10.80 $10.72▲ +0.74%▲ +0.29%$16.88 (−56.30%)
Showing 8 of 8

US Market Status

Market Closed — Opens Thu (10h 58m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access